FDA Approves Change In Storage Conditions For Humate-P

The U.S. Food and Drug Administration approved a change in the storage conditions for Humate-P, a treatment for bleeding in certain patients with hemophilia A or von Willebrand Disease (vWD). The treatment, a protein that helps blood form the clots necessary to stop bleeding, can now be safely stored for up to two years at 77 degrees Fahrenheit. Previously, Humate-P required colder, refrigerator-level temperatures for that storage length. [click link for full article]

More: continued here

Filed under: Blood on October 25th, 2007